Skip to content

Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography

Pilot Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography to Detect Breast Cancer in Patients With Increased Breast Density (Breast Imaging-Reporting And Data System (BI-RADS) Category c or d)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02995980
Enrollment
128
Registered
2016-12-19
Start date
2015-11-30
Completion date
2018-05-31
Last updated
2019-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer screening, dense breasts, dual-energy contrast-enhanced digital mammography

Brief summary

This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (BI-RADS category c or d). Eligible patients will be invited to have full-field digital mammography and dual-energy (DE) contrast-enhanced (CE) digital mammography to compare accuracy of the imaging methods for the detection of breast cancer.

Detailed description

This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (Breast Imaging-Reporting And Data System category c or d). Eligible patients will be invited to have full-field digital mammography and dual-energy (DE) contrast-enhanced (CE) digital mammography to compare accuracy of the imaging methods for the detection of breast cancer

Interventions

DEVICEDual-Energy Contrast-Enhanced (DECE) mammography

Contrast mammography

routine digital mammography

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Signed informed consent 2. At least 19 years old 3. Glomerular filtration rate\> 60 4. Heterogeneously or extremely dense breasts (BI-RADS category c or d).

Exclusion criteria

1. History of iodinated contrast allergy 2. Pregnant or lactating as determined by routine standard practice 3. Personal history of breast cancer 4. History of prior breast excisional biopsy (Patients with a history of core needle biopsy will not be excluded) 5. History of prior breast reduction mammoplasty surgery 6. History of prior breast augmentation surgery 7. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.

Design outcomes

Primary

MeasureTime frameDescription
Percent Accuracy of Contrast Mammography1 year•The primary endpoint of this study is to determine the accuracy of DE CE mammography when compared to full field digital mammography (FFDM) in patients with increased breast density (Breast Imaging-Reporting And Data System (BI-RADS) category c or d breast density).
Number of Participants With Cancer Detected1 year•The primary endpoint of this study is to detect the presence of cancer using DE CE mammography when compared to full field digital mammography (FFDM) in patients with increased breast density (BI-RADS category c or d breast density).

Secondary

MeasureTime frameDescription
Number of Call Backs With Contrast Mammography1 year•The patients identified for additional imaging based on unconfirmed findings.

Countries

United States

Participant flow

Participants by arm

ArmCount
Contrast Enhanced Mammography vs Standard Digital Mammograpm
Contrast-enhanced spectral mammography for the detection breast cancer . DECE mammography: Contrast mammography
128
Total128

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up14

Baseline characteristics

CharacteristicContrast Enhanced Mammography vs Standard Digital Mammograpm
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
28 Participants
Age, Categorical
Between 18 and 65 years
100 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
100 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
26 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Sex: Female, Male
Female
128 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 128
other
Total, other adverse events
0 / 128
serious
Total, serious adverse events
0 / 128

Outcome results

Primary

Number of Participants With Cancer Detected

•The primary endpoint of this study is to detect the presence of cancer using DE CE mammography when compared to full field digital mammography (FFDM) in patients with increased breast density (BI-RADS category c or d breast density).

Time frame: 1 year

Population: Consented 128 patients, 114 patients completed both mammograms

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Contrast Enhanced MammographyNumber of Participants With Cancer Detected3 Participants
Standard Digital MammogramNumber of Participants With Cancer Detected2 Participants
Primary

Percent Accuracy of Contrast Mammography

•The primary endpoint of this study is to determine the accuracy of DE CE mammography when compared to full field digital mammography (FFDM) in patients with increased breast density (Breast Imaging-Reporting And Data System (BI-RADS) category c or d breast density).

Time frame: 1 year

Population: Consented 128 patients, 114 patients completed both mammograms

ArmMeasureValue (NUMBER)
Contrast Enhanced MammographyPercent Accuracy of Contrast Mammography100 percentage of accuracy
Standard Digital MammogramPercent Accuracy of Contrast Mammography67 percentage of accuracy
Secondary

Number of Call Backs With Contrast Mammography

•The patients identified for additional imaging based on unconfirmed findings.

Time frame: 1 year

Population: Consented 128 patients, 114 patients completed both mammograms

ArmMeasureValue (NUMBER)
Contrast Enhanced MammographyNumber of Call Backs With Contrast Mammography10 percentage of participants
Standard Digital MammogramNumber of Call Backs With Contrast Mammography11 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026